Skip to content

Biohaven BHVN Unrealized Losses on Investments (Before Tax)

Unrealized Losses on Investments (Before Tax) at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$32K
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's unrealized losses on investments (before tax).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's unrealized losses on investments (before tax)?
Biohaven (BHVN) reported unrealized losses on investments (before tax) of $3K in Q1 2026.
How has Biohaven's unrealized losses on investments (before tax) changed year-over-year?
Biohaven's unrealized losses on investments (before tax) decreased by 90.3% year-over-year, from $31K to $3K.
What is the long-term trend for Biohaven's unrealized losses on investments (before tax)?
Over 3 years (2022 to 2025), Biohaven's unrealized losses on investments (before tax) has grown at a -100.0% compound annual growth rate (CAGR), from $196K to $0.